Home › Salivary Gland Cancer › Illinois
Salivary Gland Cancer clinical trials in Illinois
4 studies for Salivary Gland Cancer are looking for participants at sites in Illinois.
DESTINY-PANTUMOUR04
- Research Site, Decatur
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
- Carle at The Riverfront, Danville
- Carle Physician Group-Effingham, Effingham
- Carle Physician Group-Mattoon/Charleston, Mattoon
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05408845Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
- University of Chicago, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT04620187From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.